Technical Analysis for BIB - ProShares Ultra Nasdaq Biotechnology
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 80.51 | -4.82% | -4.08 |
BIB closed down 4.82 percent on Thursday, March 4, 2021, on 3.2 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Historical BIB trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Support | Bullish | 0.00% | |
Volume Surge | Other | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Multiple of Ten Bullish | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Multiple of Ten Bearish | Other | -4.82% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
200 DMA Support | about 18 hours ago | |
Down 1 ATR | about 19 hours ago | |
60 Minute Opening Range Breakdown | about 19 hours ago | |
Down 5% | about 19 hours ago | |
Down 3% | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq Industry Classification Nasdaq 100 Nasdaq Biotech Nasdaq Biotechnology Index Nasdaq Biotechnology Total Return Index
Classification
Keywords: Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq Industry Classification Nasdaq 100 Nasdaq Biotech Nasdaq Biotechnology Index Nasdaq Biotechnology Total Return Index
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 113.06 |
52 Week Low | 35.49 |
Average Volume | 139,395 |
200-Day Moving Average | 78.50 |
50-Day Moving Average | 96.84 |
20-Day Moving Average | 99.86 |
10-Day Moving Average | 93.00 |
Average True Range | 5.00 |
ADX | 30.0 |
+DI | 12.03 |
-DI | 45.92 |
Chandelier Exit (Long, 3 ATRs ) | 98.05 |
Chandelier Exit (Short, 3 ATRs ) | 93.42 |
Upper Bollinger Band | 116.74 |
Lower Bollinger Band | 82.97 |
Percent B (%b) | -0.07 |
BandWidth | 33.81 |
MACD Line | -3.30 |
MACD Signal Line | -0.70 |
MACD Histogram | -2.5936 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 91.28 | ||||
Resistance 3 (R3) | 91.78 | 88.68 | 89.49 | ||
Resistance 2 (R2) | 88.68 | 85.94 | 88.44 | 88.89 | |
Resistance 1 (R1) | 84.60 | 84.25 | 83.05 | 84.10 | 88.29 |
Pivot Point | 81.50 | 81.50 | 80.73 | 81.26 | 81.50 |
Support 1 (S1) | 77.42 | 78.76 | 75.87 | 76.92 | 72.73 |
Support 2 (S2) | 74.32 | 77.07 | 74.08 | 72.13 | |
Support 3 (S3) | 70.24 | 74.32 | 71.54 | ||
Support 4 (S4) | 69.74 |